The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis

The efficacy of recombinant human soluble thrombomodulin (rhsTM) treatment for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis

Abstract Background Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is devastating with no established treatment. This phenomenon involves disordered coagulation and excessive inflammatory reactions. As recombinant human soluble thrombomodulin (rhsTM) possesses anti-coagulative and an...

Full description

Bibliographic Details
Main Authors:	Hiroyuki Kamiya, Ogee Mer Panlaqui
Format:	Article
Language:	English
Published:	BMC 2020-03-01
Series:	BMC Pulmonary Medicine
Subjects:	Recombinant human soluble thrombomodulin Acute exacerbation Idiopathic pulmonary fibrosis Review Meta-analysis
Online Access:	http://link.springer.com/article/10.1186/s12890-020-1092-3

Similar Items

Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Takuma Isshiki, et al.
Published: (2019-05-01)

The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study
by: Masayuki Akatsuka, et al.
Published: (2020-12-01)

A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease
by: Hiroyuki Kamiya, et al.
Published: (2021-05-01)

Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
by: Yuki Asai, et al.
Published: (2020-12-01)

Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin
by: Shinshu Katayama, et al.
Published: (2017-08-01)

Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis
by: Hiroyuki Kamiya, et al.
Published: (2020-06-01)

The role of thrombomodulin lectin-like domain in inflammation
by: Li Yi-Heng, et al.
Published: (2012-03-01)

Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin
by: Takuro Arishima, et al.
Published: (2018-09-01)

Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study
by: Takahiro Kato, et al.
Published: (2018-08-01)

Recombinant Thrombomodulin Suppresses Histone-Induced Neutrophil Extracellular Trap Formation
by: Binita Shrestha, et al.
Published: (2019-10-01)

Human Soluble Recombinant Thrombomodulin, ART-123, Resolved Early Phase Coagulopathies, but Did Not Significantly Alter the 28 Day Outcome in the Treatment of DIC Associated with Infectious Systemic Inflammatory Response Syndromes
by: Shusuke Mori, et al.
Published: (2019-09-01)

Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model
by: Hirao, Shingo
Published: (2018)

Pravastatin Alleviates Radiation Proctitis by Regulating Thrombomodulin in Irradiated Endothelial Cells
by: Hyosun Jang, et al.
Published: (2020-03-01)

Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening
by: Takayuki Okamoto, et al.
Published: (2020-07-01)

Exacerbation of idiopathic pulmonary fibrosis
by: S. N. Avdeev, et al.
Published: (2020-03-01)

Effect of dengue hemorrhagic fever on thrombomodulin level
by: Hendra Widjaja, et al.
Published: (2009-10-01)

Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential
by: Takashi Ito, et al.
Published: (2019-08-01)

Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia
by: Pay, Salih, et al.
Published: (2000)

Tuberculous pneumonia-induced severe ARDS complicated with DIC in a female child: a case of successful treatment
by: Dong Tien Ngo, et al.
Published: (2018-07-01)

Thrombomodulin Regulation of Mitogen-Activated Protein Kinases
by: Hemant Giri, et al.
Published: (2019-04-01)

Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report
by: Kuniaki Hirai, et al.
Published: (2019-01-01)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
by: Hayakawa M
Published: (2017-12-01)

Clinical implications of serum thrombomodulin in PR3-ANCA-associated vasculitis
by: Zycinska K, et al.
Published: (2009-12-01)

Protective Role of Recombinant Human Thrombomodulin in Diabetes Mellitus
by: Yuko Okano, et al.
Published: (2021-08-01)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Tomoo Kishaba
Published: (2019-03-01)

Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study
by: Motoyasu Kato, et al.
Published: (2019-12-01)

Assessment of Serum Thrombomodulin in Patients with Systemic Lupus Erythematosus in Rheumatology Research Center
by: Akbarian Mahmood, et al.
Published: (2009-05-01)

Assessment of Serum Thrombomodulin in Patients with Systemic Lupus Erythematosus in Rheumatology Research Center
by: Mahmood Akbarian, et al.
Published: (2009-04-01)

Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET
by: Bruno François, et al.
Published: (2021-03-01)

Glomerular localization of thrombomodulin in human glomerulonephritis
by: 松尾, 清一, et al.
Published: (1993)

The Vitamin E Analog Gamma-Tocotrienol (GT3) and Statins Synergistically Up-Regulate Endothelial Thrombomodulin (TM)
by: Rupak Pathak, et al.
Published: (2016-11-01)

The relation of thrombomodulin G33A and C1418T gene polymorphisms to the risk of acute myocardial infarction in Egyptians
by: Wael Alkhiary, et al.
Published: (2018-01-01)

Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Yoshimasa Hachisu, et al.
Published: (2019-05-01)

Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
by: Ioannis Tomos, et al.
Published: (2021-08-01)

Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP)
by: Jean-Marc Naccache, et al.
Published: (2019-04-01)

A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia
by: Jannie M. B. Sand, et al.
Published: (2018-05-01)

Diverse echocardiographic changes in the course of hypoxia due to acute exacerbation of idiopathic pulmonary fibrosis
by: Toshimitsu Tsugu, et al.
Published: (2020-09-01)

Exacerbação aguda da fibrose pulmonar idiopática Acute exacerbation of idiopathic pulmonary fibrosis
by: Natália Melo, et al.
Published: (2009-03-01)

Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study
by: Kodai Kawamura, et al.
Published: (2017-06-01)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
by: Toshiaki Iba, et al.
Published: (2017-11-01)